Project Grant T32GM159560
- This Project Grant award of $534,450 from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports an interdisciplinary graduate pharmacology training program at the University of Pennsylvania. The program aims to prepare students for productive careers in disciplines requiring fundamental knowledge of quantitative and systems pharmacology. The training covers classical pharmacology principles as well as...
- This Project Grant award of $331,270 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to the Icahn School of Medicine at Mount Sinai (ISMMS) on July 15, 2025. The award supports the Integrated Training in Pharmacological Sciences Program (ITPSP), a 5-year initiative aimed at developing highly skilled biomedical scientists to advance drug discovery research through rigorous and ethical...
- This Project Grant award of $426,360.00 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to Case Western Reserve University (CWRU) on July 1, 2025. The funding supports an interdisciplinary Predoctoral Training Program in Molecular Pharmacology, which aims to develop innovative scientists with a strong foundation in pharmacological principles and skills required for the modern workforce. Key focus...
- This $340,192 Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports the University of Colorado Anschutz Medical Campus Pharmacology and Molecular Medicine Training Program (PHARMM). The 5-year grant provides funding for 8 predoctoral students annually to obtain broad, integrative training in pharmacology and molecular medicine. The program offers a comprehensive curriculum, research...
- The Yale Predoctoral Pharmacology Training Program (PPTP) was awarded a $426,360 project grant from the National Institute of General Medical Sciences (CFDA 93.859 - Biomedical Research and Research Training) to train an outstanding and diverse group of graduate students in the pharmacological sciences for research careers. The 5-year program will integrate fundamental pharmacological principles with modern biological science, including signal transduction, metabolism, neuroscience, and...
- The National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), awarded a $426,360 Project Grant to the Trustees of Boston University, doing business as Boston University Medical Campus, on August 15, 2025. The grant will fund a predoctoral training program in biomolecular pharmacology at Boston University that aims to prepare the next generation of independent investigators, industrial leaders, educators, and policymakers in...
- The Seattle Children's Research Institute was awarded a $166,192 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) on July 17, 2025. The grant will support the "INVENT@SC CLINICAL PHARMACOLOGY OF BIOTHERAPEUTICS" training program, which aims to educate the next generation of physician-scientists to become leaders in the clinical pharmacology of biotherapeutics. The program will provide...
- The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the Regents of the University of Minnesota, in the amount of $306,474, effective July 10, 2025 through June 30, 2030. The purpose of this new grant is to transform the Molecular Pharmacology and Therapeutics (MPAT) graduate program at the University of Minnesota to better equip students with the skills needed to conduct impactful research...
- This federal Project Grant award of $427,625 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Washington (UW). The project aims to develop a novel nano-prodrug delivery platform that targets microbiome-modulating molecules to the distal gastrointestinal tract, and integrate physiologically-based pharmacokinetic (PBPK) modeling with pharmacomicrobiomics. The key objectives...
- The National Institute of General Medical Sciences (NIGMS) awarded a $4,548,513 Project Grant under CFDA 93.859, the Biomedical Research and Research Training program, to Washington University in St. Louis. The grant will provide in-depth pre-doctoral training that integrates clinical medicine and biomedical research to train the next generation of physician-scientists. Key components of the 5-year program include a pre-clinical medical school curriculum with a "MSTP thread"...
This Project Grant award for $352,624 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports a pre-doctoral Pharmacological Sciences Training Program (PSTP) at the University of Washington. The program aims to train Ph.D.-level scientists with broad expertise across the pharmacological sciences, including cellular/molecular pharmacology, drug metabolism and toxicity, drug pharmacokinetics, and biological structure/drug design. The program provides individualized, multidisciplinary coursework and seminars, as well as non-didactic training activities such as a PSTP-specific journal club, entrepreneurship training, and grant writing workshops. The goal is to develop scientists equipped with the necessary background and tools to undertake and direct fundamental research related to drug action, metabolism, and pharmacokinetics. The award period runs from August 2025 to June 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $352.6k | 8/19/25 |